The aim of our study was to analyze The Cancer Genome Atlas (TCGA) RNA-Seq data from the colorectal cancer samples with high KLK6 expression with the goal to define KLK6-specific gene signature in the CRC for identification of potential markers of tumor progression in colorectal metastatic disease. This evidence concerns the gene KLK6 and colorectal cancer.